Legal Representation
Attorney
Laurence Rickles
USPTO Deadlines
Next Deadline
136 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
January 09, 2026
Extension Available
Until January 09, 2025
Application History
28 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 26, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 26, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Jun 26, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jun 26, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 8, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 8, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jan 8, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jan 8, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 2, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Jul 2, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jul 2, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 2, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 9, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Nov 14, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Nov 14, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 25, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Oct 10, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Oct 6, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Oct 6, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 6, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Sep 20, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 20, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Sep 20, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 18, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 16, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jul 19, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Jul 18, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 17, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Human Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, depression, psychological disorders, diabetes and diabetic neuropathy, cardiovascular and blood pressure disorders, irritable bowel syndrome, neurodegenerative diseases and disorders, osteoporosis, pain and neuropathic pain, peripheral nervous system diseases and disorders, digestive tract disorders, gastrointestinal and dermatological diseases and disorders, respiratory system diseases and disorders, sexual dysfunction, symptoms associated with uterine fibroids, urinary incontinence and overactive bladder, AIDS-related disorders, cancer, central nervous system diseases, circulatory system diseases, sensory organ diseases, urogenital organ diseases, peripheral nervous system diseases, bone disorders and bone diseases; Human Pharmaceutical preparations, namely, injectable contraceptives, contraceptive preparations, fertility enhancement preparations, and hormone replacement therapy preparations
Additional Information
Design Mark
The mark consists of a small circle, medium circle, on a swooped angle in the low right corner of a shaded rectangle and above the stylized word TEVA.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The English translation of TEVA in the mark is NATURE in Hebrew.
Classification
International Classes
005